An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
The chemokine receptor 4 (CXCR4) is a promising diagnostic and therapeutic target for the management of various cancers. CXCR4 has been utilized in immunotherapy, targeted drug delivery, and endoradiotherapy. Poly(amidoamine) [PAMAM] dendrimers are well-defined polymers with unique properties that h...
Main Authors: | Wojciech G. Lesniak, Babak Behnam Azad, Samit Chatterjee, Ala Lisok, Martin G. Pomper |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/3/655 |
Similar Items
-
High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers
by: Karla I. Garfias-Gonzalez, et al.
Published: (2015-05-01) -
Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation
by: Lesniak WG, et al.
Published: (2024-05-01) -
Kajian Dendrimer (Poly)Amidoamine (Pamam) Generasi 4 Sebagai Template Dalam Pembentukan Nanopartikel Secara In Silico
by: Yurika Sastyarina, et al.
Published: (2017-06-01) -
Nanoparticle Effects on Human Platelets in Vitro: A Comparison between PAMAM and Triazine Dendrimers
by: Alan E. Enciso, et al.
Published: (2016-03-01) -
New Advances in General Biomedical Applications of PAMAM Dendrimers
by: Renan Vinicius de Araújo, et al.
Published: (2018-11-01)